Lantern Pharma, Inc.

The momentum for this stock is not very good. Lantern Pharma, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Lantern Pharma, Inc..

News

Lantern Pharma Inc. (NASDAQ:LTRN) Sees Significant Growth in Short Interest

Zolmax Lantern Pharma Inc. (NASDAQ:LTRN - Get Free Report) was the target of a significant increase in short interest in August. As of August 15th, there was short interest totalling 233,000 shares, an...\n more…

Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Up 11.0% in August

Ticker Report Lantern Pharma Inc. (NASDAQ:LTRN - Get Free Report) saw a large increase in short interest during the month of August. As of August 15th, there was short interest totalling 233,000 shares, an...\n more…

Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Update

Zolmax Lantern Pharma Inc. (NASDAQ:LTRN - Get Free Report) saw a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 210,000 shares, a decrease of...\n more…

Q3 2024 EPS Estimates for Lantern Pharma Inc. Increased by Zacks Small Cap (NASDAQ:LTRN)

Zolmax Lantern Pharma Inc. (NASDAQ:LTRN - Free Report) - Research analysts at Zacks Small Cap boosted their Q3 2024 earnings estimates for Lantern Pharma in a research report issued to clients and...\n more…

Lantern Pharma Inc. 2024 Q2 - Results - Earnings Call Presentation

SeekingAlpha Lantern Pharma Inc. 2024 Q2 - Results - Earnings Call Presentation...\n more…

Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts Lantern Pharma Inc. (LTRN) Q2 2024 Earnings Call Transcript...\n more…